Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7

BACKGROUND—The anti-idiotypic monoclonal antibody 105AD7 mimics the tumour associated antigen 791Tgp72, expressed on 70-80% of colorectal cancers. Phase I studies have shown that the vaccine is non-toxic, and a number of patients have been immunised prior to resection of their primary tumours.
AIMS—...

Full description

Saved in:
Bibliographic Details
Main Authors: Maxwell-Armstrong, C, Durrant, L, Robins, R, Galvin, A, Scholefield, J, Hardcastle, J
Format: Artigo
Language:Inglês
Published: 1999
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727698/
https://ncbi.nlm.nih.gov/pubmed/10486371
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items